Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Non Germinal-Center B Cell Like Diffuse Large B Cell Lymphoma Results From Repeated Activation of IgM B Cells That Resist Class-Switching.

Philippe Ruminy, Ph.D, Lucile Couronné, Fabrice Jardin, MD, PhD, Francoise Parmentier, Vincianne Rainville, Camille Mauger, Jean-Michel Picquenot, MD, Bernard Lenormand, MD, Marie Cornic, Philippe Bertrand, PhD, Hervé Tilly, M.D., Christian Bastard, MD, PhD

Blood (2009) 114 (22): 318.

https://doi.org/10.1182/blood.V114.22.318.318

Published: 2009

Journal Articles

Phase I Study of RO5072759 (GA101) in Relapsed/Refractory Chronic Lymphocytic Leukemia.

Franck Morschhauser, MD, PhD, Guillaume Cartron, MD, Thierry Lamy, MD, PhD, Noel-Jean Milpied, MD, PhD, Catherine Thieblemont, MD, PhD, Hervé Tilly, M.D., Martin Weisser, MD, Joe Birkett, Ph.D., Gilles Andre Salles, MD, PhD

Blood (2009) 114 (22): 884.

https://doi.org/10.1182/blood.V114.22.884.884

Published: 2009

Journal Articles

A Phase I/II Study of RO5072759 (GA101) in Patients with Relapsed/Refractory CD20 + Malignant Disease

Gilles Andre Salles, MD, PhD, Franck Morschhauser, M.D., Guillaume Cartron, M.D., Thierry Lamy, MD, PhD, Noel-Jean Milpied, M.D., PhD, Catherine Thieblemont, M.D., Hervé Tilly, M.D., Joe Birkett, Ph.D., Mike Burgess, M.D.

Blood (2008) 112 (11): 234.

https://doi.org/10.1182/blood.V112.11.234.234

Published: 2008

Journal Articles

Effect of Rituximab and/or High-Dose Therapy with Autotransplant at Time of Relapse in Patients with Follicular Lymphoma.

Bertrand Coiffier, MD, Pauline Brice, MD, Richard Delarue, MD, Corinne Haioun, MD, Bertrand Souleau, MD, Nicolas Mounier, MD, Pierre Feugier, MD, Hervé Tilly, MD, Catherine Sebban, MD

Blood (2007) 110 (11): 386.

https://doi.org/10.1182/blood.V110.11.386.386

Published: 2007

Journal Articles

Gene Expression Profiling of Highly Purified Malignant and Non-Malignant Cells: Characterization of the Tumor-Microenvironment Cellular Synapse in De Novo Follicular Lymphoma (FL).

Karin Tarte, PhD, Céline Pangault, PhD, John de Vos, MD, PhD, Philippe Ruminy, PhD, Fabienne Sauvee, Patrick Tas, MD, Jean-Michel Picquenot, MD, Hervé Tilly, MD, PhD, Thierry Lamy, MD, PhD, Christian Bastard, MD, PhD, Thierry Fest, MD, PhD

Blood (2007) 110 (11): 355.

https://doi.org/10.1182/blood.V110.11.355.355

Published: 2007

Journal Articles

Patient-Specific Three Dimensional (3D) Dosimetry for 90 Y Ibritumomab Tiutexan (Zevalin®) in Patients with Follicular Lymphoma.

Karine Assié, PhD, Arnaud Dieudonné, PhD, Isabelle Gardin, PhD, Irène Buvat, PhD, Hervé Tilly, MD, Pierre Vera, MD

Blood (2005) 106 (11): 4780.

https://doi.org/10.1182/blood.V106.11.4780.4780

Published: 2005

Journal Articles

Histology of Lymphomas with t(3;14)(q27;q32) Correlates with the Molecular Anatomy of the Translocation.

Philippe Ruminy, PhD, Fabrice Jardin, MD, Jean-Michel Picquenot, MD, Philippe Gaulard, MD, Françoise Parmentier, Gérard Buchonnet, MD, PhD, Claire Maisonneuve, Hervé Tilly, MD, Christian Bastard, MD, PhD

Blood (2005) 106 (11): 1906.

https://doi.org/10.1182/blood.V106.11.1906.1906

Published: 2005

Journal Articles

A Very Short Mutational Hot-Spot in the IGH 5′Sμ Region Suggests That the Acquisition of a Class Switch Recombination Defect Is an Important Step Toward Lymphomagenesis.

Philippe Ruminy, PhD, Fabrice Jardin, MD, Dominique Penther, MD, Françoise Parmentier, Gérard Buchonnet, MD, PhD, Jean-Michel Picquenot, MD, Hervé Tilly, MD, Christian Bastard, MD, PhD

Blood (2005) 106 (11): 284.

https://doi.org/10.1182/blood.V106.11.284.284

Published: 2005

Journal Articles

Rituximab vs Observation after High-Dose Consolidative First-Line Chemotherapy (HDC) with Autologous Stem Cell Transplantation in Poor Risk Diffuse Large B-Cell Lymphoma. Final Analysis of the LNH98-B3 GELA Study.

Corinne Haioun, Nicolas Mounier, Jean François Emile, Pierre Feugier, Bertrand Coiffier, Hervé Tilly, Christian Recher, Christophe Fermé, Jean Gabarre, Raoul Herbrecht, Frank Morschhauser12, Christian Gisselbrecht

Blood (2005) 106 (11): 677.

https://doi.org/10.1182/blood.V106.11.677.677

Published: 2005

Journal Articles

Long Term Results of the GELA Study, R-CHOP vs. CHOP in Elderly Patients with Diffuse Large B-Cell Lymphoma.

Bertrand Coiffier, MD, Pierre Feugier, MD, Catherine Sebban, MD, Reda Bouabdallah, MD, Vincent Delwail, MD, Hervé Tilly, MD, Christian Gisselbrecht, MD, André Bosly, MD, Gilles Salles, MD, Felix Reyes, MD

Blood (2004) 104 (11): 1383.

https://doi.org/10.1182/blood.V104.11.1383.1383

Published: 2004

Journal Articles

Randomized comparison of double induction and timed-sequential induction to a “3 + 7” induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study

Sylvie Castaigne, Sylvie Chevret, Eric Archimbaud, Pierre Fenaux, Dominique Bordessoule, Hervé Tilly, Thierry de Revel, Marc Simon, Brigitte Dupriez, Michel Renoux, Maud Janvier, Jean-Michel Micléa, Xavier Thomas, Christian Bastard, Claude Preudhomme, Francis Bauters, Laurent Degos, Hervé Dombret

Blood (2004) 104 (8): 2467–2474.

https://doi.org/10.1182/blood-2003-10-3561

Published: 2004

Journal Articles

Follicular Lymphoma International Prognostic Index

Blood (2004) 104 (5): 1258–1265.

https://doi.org/10.1182/blood-2003-12-4434

Published: 2004

Journal Articles

Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients

Marc André, Nicolas Mounier, Xavier Leleu, Anne Sonet, Pauline Brice, Michel Henry-Amar, Hervé Tilly, Bertrand Coiffier, André Bosly, Pierre Morel, Corinne Haioun, Philippe Gaulard, Felix Reyes, Christian Gisselbrecht, the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

Blood (2004) 103 (4): 1222–1228.

https://doi.org/10.1182/blood-2003-04-1124

Published: 2004

Journal Articles

Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients

Karim Belhadj, Félix Reyes, Jean-Pierre Farcet, Hervé Tilly, Christian Bastard, Régis Angonin, Eric Deconinck, Frédéric Charlotte, Véronique Leblond, Eric Labouyrie, Pierre Lederlin, Jean-François Emile, Béatrice Delmas-Marsalet, Bertrand Arnulf, Elie-Serge Zafrani, Philippe Gaulard

Blood (2003) 102 (13): 4261–4269.

https://doi.org/10.1182/blood-2003-05-1675

Published: 2003

Journal Articles

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma

Hervé Tilly, Eric Lepage, Bertrand Coiffier, Michel Blanc, Raoul Herbrecht, André Bosly, Michel Attal, Georges Fillet, Catherine Guettier, Thierry Jo Molina, Christian Gisselbrecht, Félix Reyes, for the Groupe d'Etude des Lymphomes de l'Adulte

Blood (2003) 102 (13): 4284–4289.

https://doi.org/10.1182/blood-2003-02-0542

Published: 2003

Journal Articles

Intronic BCL-6 mutations are preferentially targeted to the translocated allele in t(3;14)(q27;q32) non-Hodgkin B-cell lymphoma

Fabrice Jardin, Christian Bastard, Nathalie Contentin, Françoise Parmentier, Jean-Michel Picquenot, Hervé Tilly, Freda K. Stevenson, Surinder S. Sahota

Blood (2003) 102 (5): 1872–1876.

https://doi.org/10.1182/blood-2002-12-3630

Published: 2003

Journal Articles

Prognostic Significance of T-Cell Phenotype in Aggressive Non-Hodgkin's Lymphomas

Christian Gisselbrecht, Philippe Gaulard, Eric Lepage, Bertrand Coiffier, Josette Brière, Corinne Haioun, Dominique Cazals-Hatem, André Bosly, Luc Xerri, Hervé Tilly, Françoise Berger, Reda Bouhabdallah, Jacques Diebold

Blood (1998) 92 (1): 76–82.

https://doi.org/10.1182/blood.V92.1.76.413a19_76_82

Published: 1998

Journal Articles

Primary Anaplastic Large-Cell Lymphoma in Adults: Clinical Presentation, Immunophenotype, and Outcome

Hervé Tilly, Philippe Gaulard, Eric Lepage, Charles Dumontet, Jacques Diebold, Isabelle Plantier, Françoise Berger, Michel Symann, Tony Petrella, Pierre Lederlin, Josette Brière

Blood (1997) 90 (9): 3727–3734.

https://doi.org/10.1182/blood.V90.9.3727

Published: 1997

NARROW

Non Germinal-Center B Cell Like Diffuse Large B Cell Lymphoma Results From Repeated Activation of IgM B Cells That Resist Class-Switching.

Phase I Study of RO5072759 (GA101) in Relapsed/Refractory Chronic Lymphocytic Leukemia.

A Phase I/II Study of RO5072759 (GA101) in Patients with Relapsed/Refractory CD20 + Malignant Disease

Effect of Rituximab and/or High-Dose Therapy with Autotransplant at Time of Relapse in Patients with Follicular Lymphoma.

Gene Expression Profiling of Highly Purified Malignant and Non-Malignant Cells: Characterization of the Tumor-Microenvironment Cellular Synapse in De Novo Follicular Lymphoma (FL).

Patient-Specific Three Dimensional (3D) Dosimetry for 90 Y Ibritumomab Tiutexan (Zevalin®) in Patients with Follicular Lymphoma.

Histology of Lymphomas with t(3;14)(q27;q32) Correlates with the Molecular Anatomy of the Translocation.

A Very Short Mutational Hot-Spot in the IGH 5′Sμ Region Suggests That the Acquisition of a Class Switch Recombination Defect Is an Important Step Toward Lymphomagenesis.

Rituximab vs Observation after High-Dose Consolidative First-Line Chemotherapy (HDC) with Autologous Stem Cell Transplantation in Poor Risk Diffuse Large B-Cell Lymphoma. Final Analysis of the LNH98-B3 GELA Study.

Long Term Results of the GELA Study, R-CHOP vs. CHOP in Elderly Patients with Diffuse Large B-Cell Lymphoma.

Randomized comparison of double induction and timed-sequential induction to a “3 + 7” induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study

Follicular Lymphoma International Prognostic Index

Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients

Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma

Intronic BCL-6 mutations are preferentially targeted to the translocated allele in t(3;14)(q27;q32) non-Hodgkin B-cell lymphoma

Prognostic Significance of T-Cell Phenotype in Aggressive Non-Hodgkin's Lymphomas

Primary Anaplastic Large-Cell Lymphoma in Adults: Clinical Presentation, Immunophenotype, and Outcome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only